---
title: "Umary: UMARY Hyaluronic Acid tablets — FDA announcement Nov 21, 2024 | Is It on Recall"
description: "The product contains undeclared diclofenac and omeprazole"
url: https://isitonrecall.com/recall/fdapress-3f9af5d2aac7371f-umary-umary-hyaluronic-acid-tablets/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# Umary: UMARY Hyaluronic Acid tablets — FDA announcement Nov 21, 2024

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Nov 21, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: UMARY Hyaluronic Acid tablets
- **Reason**: The product contains undeclared diclofenac and omeprazole
- **Classification**: Not supplied
- **Recalling firm**: MXBBB
- **Quantity**: Not supplied
- **Agency-reported status**: Company recall announcement
- **Source record identifier**: 3f9af5d2aac7371f

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mxbbb-issues-voluntary-nationwide-recall-umary-acid-hyaluronic-due-presence-diclofenac-and)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | MXBBB is voluntarily recalling 1 lot of UMARY ACID HYALURONIC, 30 CAPLETS 850 MG to the consumer level. The products have been found to have omeprazole and diclofenac. FDA did a laboratory analysis that confirmed that Umary contains diclofenac and omeprazole.; The product is used as dietary supplement and is packaged in a plastic container. The affected UMARY Acid hyaluronic. UPC:7502265120323 30 caplets of 850mg include the following Lot number: 24183 and the expiration date: 07/01/28. 321 units were distributed. |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

The product is used as dietary supplement and is packaged in a plastic container. The affected UMARY Acid hyaluronic. UPC:7502265120323 30 caplets of 850mg include the following Lot number: 24183 and the expiration date: 07/01/28. 321 units were distributed.

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Fda listing date**: Nov 21, 2024
- **Company announcement date**: Nov 21, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers with questions regarding this recall can contact MXBBB by email Joshua980810@outlook.com seven days a week, 24-hours a day.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mxbbb-issues-voluntary-nationwide-recall-umary-acid-hyaluronic-due-presence-diclofenac-and)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [MXBBB records](https://isitonrecall.com/brand/mxbbb/)